Digital Health Global

AUGUST 22, 2024

Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia. After earning his M.D.

Leadership 88

Leadership Pharmaceuticals Drug Development Digital Health 88

Healthcare IT Today

JANUARY 7, 2025

As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.

Health IT 93

Health IT Life Science Drug Development Pharmaceuticals 93

Healthcare IT Today

MARCH 15, 2024

We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development. According to WEF , the largest ten pharmaceutical companies have either partnered with or acquired AI companies to make use of AI-assisted drug development and design.

Pharmaceuticals 122

Pharmaceuticals Drug Development Mental health Nursing 122

Lloyd Price

JANUARY 20, 2025

Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value > [link] Healthcare Technology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.

Mental health 60

Mental health healthcare technology Telehealth Digital Health 60

Digital Health Global

MARCH 16, 2023

We are excited to support Seamless Therapeutics in its pursuit of taking a leadership position in the rapidly evolving gene editing arena,” added Karl Nägler, PhD, Managing Partner at Wellington Partners. “At Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space. Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

NOVEMBER 21, 2023

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Lloyd Price

FEBRUARY 7, 2025

Management Team: The experience, track record, and leadership of the management team can be a key factor in valuation. In conclusion, the stage of a company's development is a crucial determinant of its valuation multiple. Delays or denials can significantly impact valuation.

healthcare technology 70

healthcare technology Leadership Drug Development Pharmaceuticals 70

Digital Health Global

JUNE 20, 2023

These individuals have personally built leading technology platforms supercharging drug development globally. Their buy-in shows that our platform is differentiated and poised to unlock truly novel therapies for currently underserved patient populations through efficient, simulation-guided development. Jane Rhodes, Ph.D.,

BioTech 88

BioTech Life Science Leadership Drug Development 88

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Lloyd Price

FEBRUARY 18, 2024

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Remote care 64

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk Visit [link]

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

APRIL 22, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Pharma giants acquiring AI drug discovery firms: Pharmaceutical companies are increasingly looking to AI to streamline drug development, leading to potential acquisitions. Email lloyd@nelsonadvisors.co.uk

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

SEPTEMBER 29, 2024

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Delays or denials can significantly impact valuation.

Leadership 64

Leadership Drug Development healthcare technology Digital Health 64

Digital Health Global

NOVEMBER 7, 2024

Under this agreement, Aptar Pharma will provide extensive support to CHI, serving as the primary point of contact for customers, preparing for commercial manufacture and integrating Aptar’s comprehensive suite of pharmaceutical services to accelerate the growth of the Quattrii DPI platform.

Healthcare Innovation 88

Healthcare Innovation Pharmaceuticals Drug Development Leadership 88

Healthcare IT Today

DECEMBER 31, 2024

Mike King, Senior Director, Product and Strategy at IQVIA Increasing integration between quality, regulatory, and safety teams in pharmaceutical companies as well as the existing strong integrations in these departments in MedTech and IVD organizations.

Interoperability 65

Interoperability Health IT Pharmaceuticals Digital Health 65